165 related articles for article (PubMed ID: 34961449)
21. The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.
Scholz EMB; Kashuba ADM
Clin Pharmacol Ther; 2021 Apr; 109(4):918-927. PubMed ID: 33529355
[TBL] [Abstract][Full Text] [Related]
22. Animal models for studies of HIV-1 brain reservoirs.
Waight E; Zhang C; Mathews S; Kevadiya BD; Lloyd KCK; Gendelman HE; Gorantla S; Poluektova LY; Dash PK
J Leukoc Biol; 2022 Nov; 112(5):1285-1295. PubMed ID: 36044375
[TBL] [Abstract][Full Text] [Related]
23. HIV reservoirs as obstacles and opportunities for an HIV cure.
Chun TW; Moir S; Fauci AS
Nat Immunol; 2015 Jun; 16(6):584-9. PubMed ID: 25990814
[TBL] [Abstract][Full Text] [Related]
24. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.
North TW; Higgins J; Deere JD; Hayes TL; Villalobos A; Adamson L; Shacklett BL; Schinazi RF; Luciw PA
J Virol; 2010 Mar; 84(6):2913-22. PubMed ID: 20032180
[TBL] [Abstract][Full Text] [Related]
25. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
26. Increased T cell trafficking as adjunct therapy for HIV-1.
Fryer HR; Wolinsky SM; McLean AR
PLoS Comput Biol; 2018 Mar; 14(3):e1006028. PubMed ID: 29499057
[TBL] [Abstract][Full Text] [Related]
27. The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
Pasternak AO; Berkhout B
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578332
[TBL] [Abstract][Full Text] [Related]
28. Advances toward Curing HIV-1 Infection in Tissue Reservoirs.
Henderson LJ; Reoma LB; Kovacs JA; Nath A
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694954
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
Churchill MJ; Cowley DJ; Wesselingh SL; Gorry PR; Gray LR
J Neurovirol; 2015 Jun; 21(3):290-300. PubMed ID: 25060300
[TBL] [Abstract][Full Text] [Related]
30. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
31. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
32. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
33. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
Ananworanich J; Dubé K; Chomont N
Curr Opin HIV AIDS; 2015 Jan; 10(1):18-28. PubMed ID: 25415421
[TBL] [Abstract][Full Text] [Related]
34. Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities.
León-Rivera R; Morsey B; Niu M; Fox HS; Berman JW
mBio; 2020 Jul; 11(4):. PubMed ID: 32723919
[TBL] [Abstract][Full Text] [Related]
35. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
36. HIV Eradication Strategies: Implications for the Central Nervous System.
Veenhuis RT; Clements JE; Gama L
Curr HIV/AIDS Rep; 2019 Feb; 16(1):96-104. PubMed ID: 30734905
[TBL] [Abstract][Full Text] [Related]
37. Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective.
Aid M; Dupuy FP; Moysi E; Moir S; Haddad EK; Estes JD; Sekaly RP; Petrovas C; Ribeiro SP
Front Immunol; 2018; 9():895. PubMed ID: 29967602
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 Reservoirs During Suppressive Therapy.
Barton K; Winckelmann A; Palmer S
Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
[TBL] [Abstract][Full Text] [Related]
39. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
40. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.
Chun TW; Fauci AS
AIDS; 2012 Jun; 26(10):1261-8. PubMed ID: 22472858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
